Cleared Traditional

Mecun SpO2 sensor (K231979) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2024
Decision
408d
Days
Class 2
Risk

K231979 is an FDA 510(k) clearance for the Mecun SpO2 sensor. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Shenzhen Mecun Medical Supply Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on August 16, 2024 after a review of 408 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Shenzhen Mecun Medical Supply Co., Ltd. devices

Submission Details

510(k) Number K231979 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 05, 2023
Decision Date August 16, 2024
Days to Decision 408 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
268d slower than avg
Panel avg: 140d · This submission: 408d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 181
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K231979.
Belun Ring BLR-200 (BLR-200)
K234110 · Belun Technology Company Limited · Oct 2024
Pulse Oximeter (WS20A)
K240808 · Hunan Accurate Bio-Medical Technology Co., Ltd. · Oct 2024
OxiWear
K233827 · Oxiwear, Inc. · Aug 2024
Pulse Oximeter (AOJ-70A)
K232989 · Shenzhen AOJ Medical Technology Co., Ltd. · Jul 2024
Pulse Oximeter (MD300C228)
K232975 · Beijing Choice Electronic Technology Co., Ltd. · Jun 2024
ANNE Limb
K240305 · Sibel Health, Inc. · May 2024